Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,523 | -6,920 | -2,483 | 1,667 | -18,276 |
| Depreciation Amortization | 4,772 | 3,559 | 2,375 | 1,196 | 4,608 |
| Accounts receivable | 2,091 | 783 | -1,621 | -4,091 | 188 |
| Other Working Capital | -27,158 | -16,535 | -15,421 | -10,273 | -6,893 |
| Other Operating Activity | 712 | 557 | 2,198 | 4,384 | 1,015 |
| Operating Cash Flow | $-26,106 | $-18,556 | $-14,952 | $-7,117 | $-19,358 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 384 | -4 | N/A | 22 | -259 |
| PPE Investments | -655 | -380 | -278 | -66 | -627 |
| Purchase Of Investment | -20,000 | -27,500 | -35,000 | -35,000 | N/A |
| Other Investing Activity | 319 | 340 | -69 | -35 | 3 |
| Investing Cash Flow | $-19,952 | $-27,544 | $-35,347 | $-35,079 | $-883 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -215 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 46,682 | 41,815 | 37,343 | 38,607 | N/A |
| Financing Cash Flow | $46,467 | $41,815 | $37,343 | $38,607 | $N/A |
| Exchange Rate Effect | 64 | 26 | 7 | -37 | 225 |
| Beginning Cash Position | 17,792 | 17,792 | 17,792 | 17,792 | 37,808 |
| End Cash Position | 18,265 | 13,533 | 4,843 | 14,166 | 17,792 |
| Net Cash Flow | $473 | $-4,259 | $-12,949 | $-3,626 | $-20,016 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,106 | -18,556 | -14,952 | -7,117 | -19,358 |
| Capital Expenditure | -655 | -380 | -278 | -66 | -627 |
| Free Cash Flow | -26,761 | -18,936 | -15,230 | -7,183 | -19,985 |